Yüklüyor......
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report
Tyrosine kinase inhibitors (TKIs) have transformed the standard of care in lung cancer. A number of TKIs have been discovered that specifically target oncogenes, including MET receptor tyrosine kinase. Second-generation MET TKIs are showing improved efficacy over first-generation TKIs. Herein, we re...
Kaydedildi:
| Yayımlandı: | Cold Spring Harb Mol Case Stud |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cold Spring Harbor Laboratory Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784494/ https://ncbi.nlm.nih.gov/pubmed/33335011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/mcs.a005785 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|